Cargando…

New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study

OBJECTIVE: New oral anticoagulants (NOACs) are increasingly used both for prevention of stroke in non-valvular atrial fibrillation (NVAF) and the treatment of venous thromboembolism (VTE). In this study, we aimed to evaluate the current patterns of NOACs treatment in Turkey. Moreover, demographic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altay, Servet, Yıldırımtürk, Özlem, Çakmak, Hüseyin Altuğ, Aşkın, Lütfü, Sinan, Ümit Yaşar, Beşli, Feyzullah, Gedikli, Ömer, Tok, Özge Özden
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2017
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469081/ https://www.ncbi.nlm.nih.gov/pubmed/28100898 http://dx.doi.org/10.14744/AnatolJCardiol.2016.7472

Ejemplares similares

Autoimmune activation as a determinant of atrial fibrillation among Turks: A prospective evaluation
por: Şimşek, Barış, et al.
Publicado: (2018)

Cost-of-disease of Heart Failure in Turkey: A Delphi Panel-based Analysis of Direct and Indirect Costs
por: Çavuşoğlu, Yüksel, et al.
Publicado: (2022)

The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
por: Kılıç, Salih, et al.
Publicado: (2017)

Long-Term Prognosis of Patients with Heart Failure: Follow-Up Results of Journey HF-TR Study Population
por: Şabanoğlu, Cengiz, et al.
Publicado: (2023)

Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014)

TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022)

Retrovirology and young Turks...
por: Jeang, Kuan-Teh
Publicado: (2004)

Turking in the time of COVID
por: Arechar, Antonio A., et al.
Publicado: (2021)

Secondary prevention of coronary heart disease in elderly population of Turkey: A subgroup analysis of ELDERTURK study
por: Kilic, Salih, et al.
Publicado: (2019)

Simple and rapid assay for effect of the new oral anticoagulant (NOAC) rivaroxaban: preliminary results support further tests with all NOACs
por: Altman, Raul, et al.
Publicado: (2014)

Rationale, Design, and Methodology of the MORCOR-TURK Trial: Predictors of In-hospital MORtality in CORonary Care Patients in Turkey
por: Kahraman, Fatih, et al.
Publicado: (2023)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Reversal agents for NOACs: Connecting the dots
por: Dalal, Jamshed, et al.
Publicado: (2016)

Yüzyilin deneyinde Türk bilim adamlari
Publicado: (2008)

The Incidence of Alpha-Thalassemia in Iraqi Turks
por: Canatan, Duran
Publicado: (2012)

Management and outcomes of real-world use of non-vitamin-K oral anticoagulants (NOACs) in patients with atrial fibrillation: experience of a dedicated NOAC clinic
por: de Veer, A. J. W. M., et al.
Publicado: (2019)

Nonvitamin K antagonist oral anticoagulants (NOACs): the tide continues to come in
por: Blann, Andrew
Publicado: (2015)

Abstract 28. Novel Oral Anticoagulants (NOACs) in Microsurgery: A Review
por: Yao, Amy, et al.
Publicado: (2017)

First Experience of Cardiac Device Implantation with Remote Cardiac Support System in Turkey
por: Taylan, Gökay, et al.
Publicado: (2022)

The Views of Medical Faculty Students in Turkey Concerning the COVID-19 Pandemic
por: Aker, Servet, et al.
Publicado: (2020)

Clinical Characteristics of Patients with Newly Diagnosed Diabetic Macular Edema in Turkey: A Real-Life Registry Study—TURK-DEM
por: Eldem, Bora, et al.
Publicado: (2017)

DVT prophylaxis in critical care: role of NOACS
por: Lancé, Marcus D.
Publicado: (2019)

Yapay Big Bang'de Türk imzasi
Publicado: (2008)

President Türk Calls for Slovenia to Join CERN
Publicado: (2009)

Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Relationship Between Tei Index and PEP-Derived Myocardial Performance Index in Sinus Rhythm
por: Besli, Feyzullah, et al.
Publicado: (2015)

Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study
por: Altay, Servet, et al.
Publicado: (2017)

A rare radiodiagnostic finding: Porcelain atrium
por: Velibey, Yalçın, et al.
Publicado: (2017)

Liver Involvement in Children during the Diagnosis of Celiac Disease: A Single-Center Experience from Turkey
por: Altay, Derya, et al.
Publicado: (2022)

Consideration of NOACs (novel or non-vitamin K-dependent oral anticoagulants) in dental procedure
por: Song, Jiyoung
Publicado: (2021)

Demographic Stability on Mechanical Turk Despite COVID-19
por: Moss, Aaron J., et al.
Publicado: (2020)

Real-World Comparisons of Low-Dose NOACs versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Patients with AF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022)

Demographics of patients with heart failure who were over 80 years old and were admitted to the cardiology clinics in Turkey
por: Gök, Gülay, et al.
Publicado: (2019)

The Reversal of Bleeding Caused by New Oral Anticoagulants (NOACs): A Systematic Review and Meta-Analysis
por: Udayachalerm, Sariya, et al.
Publicado: (2018)

Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
por: Milojevic, Milan, et al.
Publicado: (2022)

NOACs vs. Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation
por: Patel, Priya, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Concomitant Use of NSAIDs or SSRIs with NOACs Requires Monitoring for Bleeding
por: Lee, Min-Taek, et al.
Publicado: (2020)

Gastrointestinal Bleeding Due to NOACs Use: Exploring the Molecular Mechanisms
por: Saviano, Angela, et al.
Publicado: (2022)

Yüzyılın deneyini CERN'deki Türk fizik i anlattı
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_1ptl8ha53rt8rkhvj3fmakbdck